CCR2 (Plozalizumab Biosimilar) antibody

Catalog No. ABIN7490920

This anti-CCR2 (Plozalizumab Biosimilar) antibody is a Humanized Monoclonal antibody detecting CCR2 (Plozalizumab Biosimilar) in FACS. Suitable for Human.

Quick Overview for CCR2 (Plozalizumab Biosimilar) antibody (ABIN7490920)

Target: CCR2 (Plozalizumab Biosimilar)

Reactivity: Human

Host: Humanized

Clonality: Monoclonal

Conjugate: This CCR2 (Plozalizumab Biosimilar) antibody is un-conjugated

Application: Flow Cytometry (FACS)

Grade: Research Grade

Product Details anti-CCR2 (Plozalizumab Biosimilar) Antibody

Purpose: Anti-CCR2 (Plozalizumab biosimilar) mAb

Characteristics: MLN-1202, MLN1202, anti-CCR2, hu1D9

Purification: Purified from cell culture supernatant by affinity chromatography

Isotype: IgG1

Application Details

Application Notes: Flow Cyt  1:100

Comment:

Research grade biosimilar. Not for use in therapeutic or diagnostic procedures for humans or animals.

Restrictions: For Research Use only

Handling

Format: Lyophilized

Reconstitution: Reconstitute with deionized water

Buffer: Lyophilized from sterile PBS, pH 7.4. Normally 5 % - 8 % trehalose is added as protectants before lyophilization.

Storage: -20 °C,-80 °C

Storage Comment: Store at -20°C to -80°C for 12 months in lyophilized form. After reconstitution, if not intended for use within a month, aliquot and store at -80°C (Avoid repeated freezing and thawing). Lyophilized proteins are shipped at ambient temperature.

Expiry Date: 12 months

Target Details for CCR2 (Plozalizumab Biosimilar)

Target: CCR2 (Plozalizumab Biosimilar)

Target Type: Biosimilar

Background: CC-CKR-2, CCR2A, CCR2B, CD192, CKR2, CKR2A, CKR2B, CMKBR2, MCP-1-R

UniProt: P41597